These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19691215)

  • 41. Flow cytometric DNA analysis of cirrhotic liver cells in patients with hepatocellular carcinoma can provide a new prognostic factor.
    Ruà S; Comino A; Fruttero A; Torchio P; Bouzari H; Taraglio S; Torchio B; Capussotti L
    Cancer; 1996 Sep; 78(6):1195-202. PubMed ID: 8826940
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High expression of vanilloid receptor-1 is associated with better prognosis of patients with hepatocellular carcinoma.
    Miao X; Liu G; Xu X; Xie C; Sun F; Yang Y; Zhang T; Hua S; Fan W; Li Q; Huang S; Wang Q; Liu G; Zhong D
    Cancer Genet Cytogenet; 2008 Oct; 186(1):25-32. PubMed ID: 18786439
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Receptor activator of nuclear factor-kappaB ligand (RANKL) expression in hepatocellular carcinoma with bone metastasis.
    Sasaki A; Ishikawa K; Haraguchi N; Inoue H; Ishio T; Shibata K; Ohta M; Kitano S; Mori M
    Ann Surg Oncol; 2007 Mar; 14(3):1191-9. PubMed ID: 17195907
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic significance of osteopontin in hepatitis B virus-related hepatocellular carcinoma.
    Xie H; Song J; Du R; Liu K; Wang J; Tang H; Bai F; Liang J; Lin T; Liu J; Fan D
    Dig Liver Dis; 2007 Feb; 39(2):167-72. PubMed ID: 17161983
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma.
    Roncalli M; Bianchi P; Bruni B; Laghi L; Destro A; Di Gioia S; Gennari L; Tommasini M; Malesci A; Coggi G
    Hepatology; 2002 Aug; 36(2):427-32. PubMed ID: 12143052
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Significance of vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma].
    Zhao J; Hu J; Cai J
    Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):389-92. PubMed ID: 11810769
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical significance of mrp gene in primary hepatocellular carcinoma.
    Wang BL; Chen XP; Zhai SP; Chen DF
    Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):397-403. PubMed ID: 14599947
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alterations of p53, Bcl-2, and hMSH2 protein expression in the cirrhotic, macroregenerative, dysplastic nodules and hepatocellular carcinomas in Upper Egypt.
    Hussein MR
    Liver Int; 2004 Dec; 24(6):552-60. PubMed ID: 15566504
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Elevated Serum Levels of the Antiapoptotic Protein Decoy-Receptor 3 Are Associated with Advanced Liver Disease.
    Bamias G; Gizis M; Delladetsima I; Laoudi E; Siakavellas SI; Koutsounas I; Kaltsa G; Vlachogiannakos J; Vafiadis-Zouboulis I; Daikos GL; Papatheodoridis GV; Ladas SD
    Can J Gastroenterol Hepatol; 2016; 2016():2637010. PubMed ID: 27595094
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Over-expression of decoy receptor 3 in gastric precancerous lesions and carcinoma.
    Chen G; Luo D
    Ups J Med Sci; 2008; 113(3):297-304. PubMed ID: 18991242
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Overexpression of decoy receptor 3 in hepatocellular carcinoma and its association with resistance to Fas ligand-mediated apoptosis.
    Shen HW; Gao SL; Wu YL; Peng SY
    World J Gastroenterol; 2005 Oct; 11(38):5926-30. PubMed ID: 16273601
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The expression of EMS1 and DcR3 protein in laryngeal carcinoma and the relation between EMS1 and DcR3].
    Li L; Yue Z; Lu H; Zhang Y; Liu C; Gao S; Yue W
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Dec; 24(24):1126-8, 1141. PubMed ID: 21395182
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Decoy receptor 3 enhances tumor progression via induction of tumor-associated macrophages.
    Tai SK; Chang HC; Lan KL; Lee CT; Yang CY; Chen NJ; Chou TY; Tarng DC; Hsieh SL
    J Immunol; 2012 Mar; 188(5):2464-71. PubMed ID: 22287720
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aberrant expression of decoy receptor 3 in human breast cancer: relevance to lymphangiogenesis.
    Wu Q; Zheng Y; Chen D; Li X; Lu C; Zhang Z
    J Surg Res; 2014 May; 188(2):459-65. PubMed ID: 24612949
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SH2D4A is frequently downregulated in hepatocellular carcinoma and cirrhotic nodules.
    Quagliata L; Andreozzi M; Kovac M; Tornillo L; Makowska Z; Moretti F; Heim MH; Heinimann K; Piscuoglio S; Terracciano LM
    Eur J Cancer; 2014 Mar; 50(4):731-8. PubMed ID: 24315626
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of death decoy receptor-3 (DcR3) in human breast cancer and its functional effects on breast cancer cells in vitro.
    Ge Z; Sanders AJ; Ye L; Wang Y; Jiang WG
    J Exp Ther Oncol; 2011; 9(2):109-18. PubMed ID: 21699018
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of heparanase in hepatocellular carcinoma has prognostic significance: a tissue microarray study.
    Chen G; Dang YW; Luo DZ; Feng ZB; Tang XL
    Oncol Res; 2008; 17(4):183-9. PubMed ID: 18773863
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endothelial transdifferentiation in hepatocellular carcinoma: loss of Stabilin-2 expression in peri-tumourous liver correlates with increased survival.
    Géraud C; Mogler C; Runge A; Evdokimov K; Lu S; Schledzewski K; Arnold B; Hämmerling G; Koch PS; Breuhahn K; Longerich T; Marx A; Weiss C; Damm F; Schmieder A; Schirmacher P; Augustin HG; Goerdt S
    Liver Int; 2013 Oct; 33(9):1428-40. PubMed ID: 23870052
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Decoy receptor 3 is a prognostic factor in renal cell cancer.
    Macher-Goeppinger S; Aulmann S; Wagener N; Funke B; Tagscherer KE; Haferkamp A; Hohenfellner M; Kim S; Autschbach F; Schirmacher P; Roth W
    Neoplasia; 2008 Oct; 10(10):1049-56. PubMed ID: 18813347
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum decoy receptor 3, a potential new biomarker for sepsis.
    Hou YQ; Xu P; Zhang M; Han D; Peng L; Liang DY; Yang S; Zhang Z; Hong J; Lou XL; Zhang L; Kim S
    Clin Chim Acta; 2012 Apr; 413(7-8):744-8. PubMed ID: 22280900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.